Word

MICROMET

Status

Dead

Status Code

710

Status Date

Friday, June 22, 2012

Serial Number

76444543

Registration Number

3014387

Registration Date

Tuesday, November 15, 2005

Mark Type

1000

Filing Date

Wednesday, August 28, 2002

Published for Opposition

Tuesday, October 26, 2004

Cancellation Date

Friday, June 22, 2012

Trademark Owner History

MICROMET AG - Original Registrant

Classifications

1 Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives all for scientific purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with florescence activated cell sorting FACS devices or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes

5 Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases,osteoporosis, graft versus host and host versus graft diseases, transplant rejection,coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders,neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases,proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases; and minimal residual diseases; restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis,immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use, eukaryotic cells,eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture and, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micro metastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACSor with receptor/ligand binding, of cells of chemically fixed tissue, of micrometasttic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto immune diseases,inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases,restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy,rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases,neurodegenerative diseases; sanitary preparations for medical purposes, namely, agents for dental care

9 Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, fluorescence activated cell sorting FACS devices, lasers, balloon instruments and magnetic devices, for scientific research purposes, all for the development of medicaments, identification and analysis of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides

10 Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Flourescence Activated Cell Sorting FACS devices, lasers, balloon instruments and magnetic devices, for clinical medical purposes, all for the clinical diagnosis and analysis for animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material

42 Scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, in the field of molecular biology, biotechnology, genetics, medicine, pharmacology, cell biology; identification of target structures for the development of medicaments, identification of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; development of technologies and means for scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, namely, of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; performance of diagnoses and analyses for medical research purposes; eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides

Trademark Events

Jun 22, 2012

Cancelled Sec. 8 (6-Yr)

Nov 15, 2005

Registered-Principal Register

Oct 6, 2005

Data Modification Completed

Oct 2, 2005

Teas Change Of Correspondence Received

Jul 20, 2005

Teas Change Of Correspondence Received

Jun 28, 2005

1(B) Basis Deleted; Proceed To Registration

Jun 28, 2005

Notice Of Allowance Cancelled

May 24, 2005

Noa Mailed - Sou Required From Applicant

Mar 26, 2005

Extension Of Time To Oppose Process - Terminated

Feb 18, 2005

Fax Received

Nov 22, 2004

Extension Of Time To Oppose Received

Oct 26, 2004

Published For Opposition

Oct 6, 2004

Notice Of Publication

Jul 14, 2004

Approved For Pub - Principal Register

Jun 19, 2004

Examiner's Amendment Entered

Jun 22, 2004

Examiners Amendment Mailed

May 10, 2004

Examiners Amendment Mailed

Mar 15, 2004

Correspondence Received In Law Office

Mar 15, 2004

Paper Received

Mar 1, 2004

Continuation Of Final Refusal Mailed

Nov 12, 2003

Correspondence Received In Law Office

Nov 17, 2003

Correspondence Received In Law Office

Nov 17, 2003

Paper Received

Oct 7, 2003

Correspondence Received In Law Office

Nov 8, 2003

Case File In Ticrs

Oct 10, 2003

Paper Received

Jul 28, 2003

Final Refusal Mailed

Jun 23, 2003

Correspondence Received In Law Office

Jun 23, 2003

Paper Received

May 16, 2003

Correspondence Received In Law Office

May 16, 2003

Paper Received

Dec 10, 2002

Non-Final Action Mailed

Nov 18, 2002

Assigned To Examiner